Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abeona Therapeutics (NQ: ABEO ) 5.930 +0.170 (+2.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abeona Therapeutics < Previous 1 2 3 4 5 Next > Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences September 03, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 02, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors August 14, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel August 13, 2024 CMS grants ICD-10-PCS product-specific procedure code and favorable DRG assignment for pz-cel, supporting efficient hospital billing, reimbursement and patient access From Abeona Therapeutics Inc. Via GlobeNewswire ABEO Stock Earnings: Abeona Therapeutics Beats EPS for Q2 2024 August 12, 2024 ABEO stock results show that Abeona Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission August 12, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 01, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications July 11, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum July 08, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 03, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers May 31, 2024 Via AB Newswire Exposures Product Safety 12 Health Care Stocks Moving In Thursday's After-Market Session May 30, 2024 Via Benzinga Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference May 28, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024 May 15, 2024 ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress May 15, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 07, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants May 03, 2024 From Abeona Therapeutics Inc. Via GlobeNewswire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors May 02, 2024 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors May 01, 2024 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors April 29, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Crude Oil Moves Higher; General Motors Earnings Top Views April 23, 2024 Via Benzinga Exposures Fossil Fuels Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 23, 2024 Via Benzinga Dow Jumps Over 200 Points; US Services PMI Falls In April April 23, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Affirm (AFRM) Stock Moving Today? April 23, 2024 Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores. Via InvestorPlace US Stocks Higher; PepsiCo Posts Upbeat Earnings April 23, 2024 Via Benzinga FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink April 23, 2024 Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements. Via Benzinga Exposures Product Safety Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today? April 23, 2024 Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement. Via InvestorPlace Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? April 23, 2024 Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel. Via InvestorPlace Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 23, 2024 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.